SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018927
Filing Date
2023-05-08
Accepted
2023-05-08 17:29:46
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20230331.htm   iXBRL 10-Q 2164679
2 EX-31.1 acad-ex31_1.htm EX-31 13453
3 EX-31.2 acad-ex31_2.htm EX-31 13708
4 EX-32.1 acad-ex32_1.htm EX-32 9846
5 EX-32.2 acad-ex32_2.htm EX-32 9904
  Complete submission text file 0000950170-23-018927.txt   8057782

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20230331_pre.xml EX-101.PRE 259245
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20230331_def.xml EX-101.DEF 121230
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20230331.xsd EX-101.SCH 44355
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acad-20230331_cal.xml EX-101.CAL 52305
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20230331_lab.xml EX-101.LAB 352502
55 EXTRACTED XBRL INSTANCE DOCUMENT acad-20230331_htm.xml XML 1719819
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 23899096
SIC: 2834 Pharmaceutical Preparations